Altuva's analysis of S&P Capital IQ data tracked 3,238 below-NAV companies from the 2015 vintage over a full ten-year period to 2025. The cohort was defined as all publicly listed companies with a price-to-book ratio below 1.0x as of the start of the observation period. Outcomes were classified into four categories: recovered (P/B returned above 1.0x), remained below NAV, declined further, and exited via delisting, bankruptcy, or acquisition at a discount.
Outcomes for below-NAV companies over 10 years
2015 vintage cohort, n=3,238 companies tracked 2015 to 2025
Source: Altuva Group analysis, S&P Capital IQ. 2015 vintage cohort. n=3,238 below-NAV companies. Outcomes tracked 2015–2025.
The headline result: only 34% of below-NAV companies recovered to above-NAV over a full ten-year period.1 The remaining 66% experienced one of three outcomes 44% remained persistently below NAV, 17% saw their discount deepen rather than narrow, and 5% exited the market via delisting, bankruptcy, or an acquisition that returned shareholders far less than intrinsic value.
The second data asset compounds the case. Altuva's analysis also tracked the average price-to-book ratio of the entire below-NAV universe across two decades. In 2005, the average P/B of below-NAV companies stood at 0.67x. By 2010, it had compressed to 0.61x. By 2015, it was 0.62x. By 2020, it had fallen to 0.34x. By 2025, it reached 0.30x. The universe of below-NAV companies has not been recovering toward fair value. As a group, it has been drifting further from it.
The cohort
3,238
Below-NAV companies in the 2015 vintage cohort, tracked 2015–2025. Source: Altuva Group analysis, S&P Capital IQ.
The 20-year trend
-55%
Decline in average P/B of the below-NAV universe from 0.67x (2005) to 0.30x (2025). The average below-NAV company has gotten cheaper relative to book over two decades, not more expensive.
Precedent transactions
1,500+
Below-NAV US <$300M control transactions executed 2005–2025. ~80% completion rate. ~0.6x median P/B at entry.
Value investing has a long theoretical and empirical foundation. Stocks trading below book value have historically outperformed the market over long horizons. The academic literature, from Graham and Dodd through to Fama and French's three-factor model, supports the view that cheap assets tend to re-rate toward fair value over time. For a diversified portfolio of value stocks, the mean reversion argument has substantial empirical backing.
The data presented here does not contradict that argument for a diversified portfolio. It challenges it at the individual company level which is the level that matters for shareholders, boards, and anyone considering whether to wait or act.
At the individual company level, a 34% recovery rate means that for every company that re-rated, two companies in the same cohort did not. The 44% that remained below NAV after ten years were not companies that were "almost there" they were companies for which a full decade of market activity produced no correction. And the 17% that declined further were not just stagnant: they suffered ongoing erosion of the gap between market price and intrinsic value across a full economic cycle that included a global pandemic, a post-COVID recovery, and one of the longest bull markets in market history.
The second challenge to the "wait and recover" thesis comes from the aggregate P/B trend. If mean reversion were functioning, one would expect the average P/B of the below-NAV universe to drift upward toward 1.0x over time. The opposite has occurred. The average fell from 0.67x in 2005 to 0.30x in 2025 a decline of more than half across two decades.1 The universe of below-NAV companies is not thinning out as companies recover. It is deepening as new companies enter it faster than existing ones exit.
What actually drives recovery
The 34% that did recover did not recover because markets spontaneously reappraised them. Recovery in this cohort is overwhelmingly driven by catalysts: M&A activity, activist intervention, changes in capital allocation policy, or structural transactions that unlocked balance sheet value. The companies that recovered had, in some form, a buyer or an intervention. The companies that did not recover had neither.
The precedent transaction data supports this. Over 1,500 below-NAV, sub-$300M control transactions were executed in the US and Canada between 2005 and 2025, at a median P/B of approximately 0.6x and an ~80% completion rate.2 These transactions produced shareholder value. But 92% of acquirers in this universe completed only one transaction, and just two acquirers ever executed three or more deals.2 The strategy is proven. It has simply never been industrialised.
What happens without a structured buyer
Market Cap Collapse
Plant-based food manufacturer. Five production facilities, $200M+ revenue. Burned $126M in cash in two years.
Tangible book value
$86.9M
Market cap at trough (Jul 2023)
$13.4M
P / TBV
0.15x
Shareholder Recovery
$0
Velo3D
VLD
Delisted to OTC
Metal 3D printing manufacturer. Built inventory ahead of demand that never came. Cash fell from $208M to $31M in two years.
Tangible book value
$68.3M
Market cap at trough (Jun 2024)
$28.6M
P / TBV
0.42x
Shareholder Recovery
~5% ownership
Lordstown Motors
RIDE
Bankruptcy
EV manufacturer. $222M in liquid assets with no liabilities to service. Burned $282M in one year on a truck that could not be built.
Tangible book value
$351.8M
Market cap (Dec 2022)
$243.8M
P / TBV
0.7x
Shareholder Recovery
~8% of value
All three companies carried substantial tangible asset value at the time of distress. All three lacked a structured counterparty willing to acquire control and realise that value before it was consumed. The outcomes zero shareholder recovery, 5% recovery via dilution, and ~92% of value lost to bankruptcy proceedings are not edge cases. They are the modal outcome for the 17% of below-NAV companies whose discounts deepened materially.
The recovery breakdown
34% recovered above 1.0x P/B within 10 years
44% remained below NAV no correction after a full decade
17% declined further discount deepened materially
5% exited via delisting, bankruptcy, or distressed sale
The acquirer landscape
92% of all acquirers completed only one transaction
Only 2 acquirers ever executed 3+ deals
~60-day median close on completed deals
Strategy is proven. It has never been industrialised
The data makes one point with particular clarity: for the 61% of below-NAV companies that either remained stuck or declined further, doing nothing was not a neutral decision. It was a decision to accept ongoing capital erosion, continued listing costs, and the steady reduction of options as the discount deepened.
Every year a below-NAV company remains listed, it incurs public company costs audit fees, legal, D&O insurance, compliance, exchange fees estimated at $1.5–$2.5M annually for a typical small-cap issuer. For a company with a $20M tangible book value, that represents 7–12% of its asset base consumed each year in overhead, without any corresponding improvement in the valuation multiple. The companies that recovered did so quickly enough that these costs were a manageable drag. The companies that remained below NAV for a decade paid those costs for ten years without recovery.
The precedent transaction data provides the empirical answer to what a structured intervention produces. Over 1,500 below-NAV, sub-$300M control transactions were executed between 2005 and 2025, completing at an ~80% rate at a median P/B of ~0.6x. These transactions produced the catalyst that two-thirds of the cohort never had: a buyer willing to pay a premium to market, acquire control, and realise balance sheet value on a defined timeline rather than an indefinite one.
The Structural Implication
The below-NAV cohort divides cleanly into two groups: those that had a catalyst (buyer, activist, strategic change) and recovered; and those that did not, and remained stuck or deteriorated. The question for any below-NAV company is not whether it deserves to trade above book value. Most of them do. The question is whether there is a mechanism available to close the gap and for the 66% majority, there was not.
Altuva is designed to be that mechanism. Not for every company in the universe, but for the sub-$300M segment that no scaled acquirer has ever served systematically.
The average P/B of the below-NAV universe has fallen from 0.67x in 2005 to 0.30x in 2025 a decline of more than half across two decades. This is not consistent with mean reversion. It is consistent with a structural dynamic in which the forces creating the discount are stronger than the forces correcting it. Those forces the withdrawal of analyst coverage, the displacement of active investors by passive funds, and the regulatory tightening that compresses the time available to act have been documented in the preceding articles of this series and are intensifying, not abating.
The empirical spine beneath all five prior articles in this series is the data presented here. The discount is not temporary. For most companies in it, the market has structurally decided not to price them fairly and the evidence across a full decade, across 3,238 companies, across wildly different macro environments, shows that two-thirds of them will never recover on their own.
That is the data case against waiting. And it is the empirical foundation for what Altuva is built to do.
Annual cost of waiting
$2M+
Estimated annual public company overhead for a typical small-cap issuer. For a $20M book-value company, that is 10%+ of asset base consumed per year with no improvement in the valuation multiple.
The Altuva thesis
34% of below-NAV companies recovered almost all via a specific catalyst
66% did not they lacked a buyer or an intervention
Altuva provides the missing catalyst: a scaled, board-friendly platform executing control acquisitions at speed
1,500+ precedent transactions confirm the strategy works it has never been industrialised
The Empirical
Spine
This is the data that underpins every other argument in this series. The analyst coverage article explains why the discount forms. The passive investing article explains why it persists. The NASDAQ article explains why the window is closing. This article shows what happens to the companies inside it.
Two-thirds never recover. Not because the assets aren't there. Because the catalyst isn't.
The data case is this: a company trading below book value is not, by that fact alone, likely to recover. It is likely to remain below book value. Across 3,238 companies tracked over ten years through a pandemic, a recovery, and a bull market 66% saw no improvement or deteriorated.
The companies that recovered did so because something happened. A buyer emerged. An activist took a position. A board made a decisive capital allocation change. The companies that did not recover were waiting for something that never came.
The average P/B of the below-NAV universe has fallen from 0.67x to 0.30x over twenty years.1 The universe is not shrinking through recovery. It is deepening. And the structural forces that produce it passive investing's displacement of active price discovery, the withdrawal of analyst coverage below $300M, and the tightening regulatory timeline are all intensifying simultaneously.
Altuva was built as the counterparty for the two-thirds that would otherwise never recover. A listed platform that provides the catalyst the buyer, the premium, the transaction that the data shows is the only reliable path to value realisation for companies the market has structurally decided to ignore.
Sources & Footnotes
Altuva Group, proprietary analysis, S&P Capital IQ data. 2015 vintage cohort of all publicly listed companies with price-to-book ratio below 1.0x at the start of the observation period. n=3,238 companies. Outcomes tracked 2015–2025. Recovery defined as price-to-book ratio returning above 1.0x within the 10-year window. Declined defined as material deepening of the discount. Exited defined as delisting, bankruptcy filing, or acquisition at a sub-NAV price. P/B time series (2005–2025) reflects the average price-to-book ratio of all below-NAV publicly listed companies across major global exchanges at each observation date. Internal analysis. All figures subject to confirmation by Altuva Group.
S&P Capital IQ. US and Canada below-NAV, sub-$300M market cap control transactions, 2005–2025. 1,500+ transactions. ~80% completion rate. ~0.6x median P/B at entry. ~60-day median close. 92% of all acquirers completed only one transaction. Only 2 acquirers executed 3 or more deals. As cited in Altuva Group investor presentation, April 2026.
Tattooed Chef, Inc. (NASDAQ: TTCF). Balance sheet data from 10-K, December 2022. Tangible book value $86.9M. Market cap at trough (July 2023): $13.4M. P/TBV: 0.15x. Chapter 11 filed July 2023. Brand auctioned for $1.5M. All value consumed by the bankruptcy process. Shareholder recovery: $0. Filed with SEC; public record.
Velo3D Inc. (NYSE: VLD). Balance sheet data from 10-K, December 2023. Tangible book value $68.3M. Cash fell from $208M to $31M over two years. Market cap at trough (June 2024): $28.6M. P/TBV: 0.42x. NYSE forced delisting September 2024; stock moved to OTC. Distressed fund acquired 95% via debt-for-equity swap. Original shareholders diluted to ~5%. Filed with SEC; public record.
Lordstown Motors Corp. (NASDAQ: RIDE). Balance sheet data from 10-K, December 2022. Tangible book value $351.8M. Cash and investments $221.7M. PP&E $193.8M. Market cap: $243.8M. P/TBV: 0.7x. Burned $282M in one year. Chapter 11 filed June 2023. Factory sold to Foxconn for $230M. $993M NOLs preserved for successor entity. Shareholder recovery: approximately 8% of peak value. Filed with SEC; public record.
Category Differentiation Priced; AI Monetisation Validated